The Multi-center,Open-label,Single Arm Clinical Trial of Efficacy and Safety of PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy
Latest Information Update: 24 Jun 2016
At a glance
- Drugs Pegfilgrastim (Primary)
- Indications Neutropenia
- Focus Adverse reactions
- Sponsors CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
- 24 Jun 2016 New trial record